BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

The actual “same old story” will be the sophisticated investors...

  1. 1,167 Posts.
    lightbulb Created with Sketch. 448
    The actual “same old story” will be the sophisticated investors selling into the SP rise in anticipation of trial results. This rise will of course be juiced by same investors. They will be well gone by the time the trial results are released.

    It’s not in their makeup to hold into disappointment.

    The only potential suprise will be how the poor trial results will be spun this time?


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.